The Revised Fibromyalgia Impact Questionnaire (FIQR): validation and psychometric properties
Open accessThe DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Abstract
Introduction: The Fibromyalgia Impact Questionnaire (FIQ) is a commonly used instrument in the evaluation of fibromyalgia (FM) patients. Over the last 18 years, since the publication of the original FIQ, several deficiencies have become apparent and the cumbersome scoring algorithm has been a barrier to widespread clinical use. The aim of this paper is to describe and validate a revised version of the FIQ: the FIQR. Methods: The FIQR was developed in response to known deficiencies of the FIQ with the help of a patient focus group. The FIQR has the same 3 domains as the FIQ (that is, function, overall impact and symptoms). It differs from the FIQ in having modified function questions and the inclusion of questions on memory, tenderness, balance and environmental sensitivity. All questions are graded on a 0–10 numeric scale. The FIQR was administered online and the results were compared to the same patient's online responses to the 36-Item Short Form Health Survey (SF-36) and the original FIQ. Results: The FIQR was completed online by 202 FM patients, 51 rheumatoid arthritis (RA) or systemic lupus erythematosus (SLE) patients (31 RA and 20 SLE), 11 patients with major depressive disorder (MDD) and 213 healthy controls (HC). The mean total FIQR score was 56.6 ± 19.9 compared to a total FIQ score of 60.6 ± 17.8 ( P < 0.03). The total scores of the FIQR and FIQ were closely correlated ( r = 0.88, P < 0.001). Each of the 3 domains of the FIQR correlated well with the 3 related FIQ domains ( r = 0.69 to 0.88, P < 0.01). The FIQR showed good correlation with comparable domains in the SF-36, with a multiple regression analysis showing that the three FIQR domain scores predicted the 8 SF-36 subscale scores. The FIQR had good discriminant ability between FM and the 3 other groups; total FIQR scores were HC (12.1 ± 11.6), RA/SLE (28.6 ± 21.2) and MDD (17.3 ± 11.8). The patient completion time was 1.3 minutes; scoring took about 1 minute. Conclusions: The FIQR is an updated version of the FIQ that has good psychometric properties, can be completed in less than 2 minutes and is easy to score. It has scoring characteristics comparable to the original FIQ, making it possible to compare past FIQ results with future FIQR results.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures




Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“The FIQR is a 21-item, validated self-report instrument that assesses function, overall impact, and symptoms over the past seven days.22”
From Mindfulness is associated with psychological health and moderates the impact of fibromyalgia (2019) · cites this paper as [22]
The cited source says what the claim attributes to it.
In the citing paper
“All the included studies referred to the original version of the FIQ score [46]: the revised version of the FIQ was not used [47].”
From Duloxetine for fibromyalgia syndrome: a systematic review and meta-analysis (2023) · cites this paper as [47]
In the citing paper
“validated clinical questionnaires for FM and IC/BPS”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(1992) · PubMed · Cited by 33,716
The MOS 36-ltem Short-Form Health Survey (SF-36): I. Conceptual Framework and Item Selection
Ware, J. E., & Sherbourne, C. D. (1992) · Medical Care · doi:10.1097/00005650-199206000-00002 · Cited by 30,033
The american college of rheumatology 1990 criteria for the classification of fibromyalgia
Wolfe, F., Smythe, H. A., Yunus, M. B., Bennett, R. M., Bombardier, C., Goldenberg, D. L., Tugwell, P., Campbell, S. M., Abeles, M., Clark, P., et al. (1990) · Arthritis & Rheumatism · doi:10.1002/art.1780330203 · Cited by 9,563
Self-citationInternational Classification of Functioning Disability and Health (ICF)
Battistella, L. R., & Brito, C. M. M. D. (2002) · Acta Fisiátrica · doi:10.5935/0104-7795.20020003 · Cited by 4,446
Core outcome measures for chronic pain clinical trials: IMMPACT recommendations
Dworkin, R. H., Turk, D. C., Farrar, J. T., Haythornthwaite, J. A., Jensen, M. P., Katz, N. P., Kerns, R. D., Stucki, G., Allen, R. R., Bellamy, N., et al. (2005) · Pain · doi:10.1016/j.pain.2004.09.012 · Cited by 3,732 · cited 2×
“Our favorable experience with the use of a numeric rating scale compared to continuous VAS scoring reflects the experience of several other groups [21,22,23] and is in line with the recommendations of the Initiative on Methods, Measurement, and Pain Assessment in Clinical Trials (IMMPACT) [24].”
MethodCore outcome domains for chronic pain clinical trials: IMMPACT recommendations
Turk, D. C., Dworkin, R. H., Allen, R. R., Bellamy, N., Brandenburg, N., Carr, D. B., Cleeland, C., Dionne, R., Farrar, J. T., Galer, B. S., et al. (2003) · Pain · doi:10.1016/j.pain.2003.08.001 · Cited by 3,510
(1991) · PubMed · Cited by 1,837
Self-citationAn internet survey of 2,596 people with fibromyalgia
Bennett, R. M., Jones, J., Turk, D. C., Russell, I. J., & Matallana, L. (2007) · BMC Musculoskeletal Disorders · doi:10.1186/1471-2474-8-27 · Cited by 865 · cited 7×
“Functioning, Disability and Health (ICF) guidelines [8] and patient surveys from the USA [9] and Germany [10].”
BackgroundInfluentialSelf-citationBennett, R. M. (2005) · PubMed · Cited by 623
Self-citationNeurocognitive impairment in drug-free patients with major depressive disorder
Porter, R. J., Gallagher, P., Thompson, J. M., & Young, A. H. (2003) · British Journal of Psychiatry · doi:10.1192/bjp.182.3.214 · Cited by 519 · cited 1×
“The scores on Memory were similar in the FM group and the MDD group, probably an expression of the well documented memory problems associated with depressive illness [18,19].”
Result
Cited by
Items 201–300 of 815
Modifiable Psychological Factors Affecting Functioning in Fibromyalgia
Paschali, M., Lazaridou, A., Paschalis, T., Napadow, V., & Edwards, R. R. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10040803 · Cited by 32
“The FIQR has good psychometric properties and has a good discriminant ability between patients with FM and rheumatoid arthritis, systemic lupus erythematosus, and major depressive disorder [38].”
BackgroundFibromyalgia influences health-related quality of life and disease activity in psoriatic arthritis
Kancharla, H., Jain, S., Mishra, S. K., Acharya, N., Grover, S., Dogra, S., & Sharma, A. (2021) · Rheumatology International · doi:10.1007/s00296-021-04925-0 · Cited by 23
Samartin-Veiga, N., González-Villar, A. J., Pidal-Miranda, M., Vázquez-Millán, A., & Carrillo‐de‐la‐Peña, M. T. (2022) · Quality of Life Research · doi:10.1007/s11136-022-03106-1 · Cited by 30
“1 3 The Fibromyalgia Impact Questionnaire revised (FIQR) [59, 60].”
BackgroundMethodInfluentialManagement of widespread pain and fibromyalgia
Whibley, D., Dean, L. E., & Basu, N. (2016) · Current Treatment Options in Rheumatology · doi:10.1007/s40674-016-0056-5 · Cited by 23
Catella, S., Gendreau, R. M., Kraus, A. C., Vega, N., Rosenbluth, M. J., Soefje, S., Malhotra, S., Luciano, J. V., McCracken, L. M., Williams, D. A., et al. (2024) · Journal of Behavioral Medicine · doi:10.1007/s10865-023-00429-3 · Cited by 23
“…14% improvement was determined to repre - sent the minimal clinically important difference (MCID) during validation of the original FIQ instrument (Bennett et al., 2009 ), an improvement of ≥ 20% has been adopted in several studies as a more stringent threshold for MCID (Bernardy et al., 2019 ;…”
MethodExploring Genetic Susceptibility to Fibromyalgia
Park, D.-J., Kang, J., Yim, Y., Kim, J.-E., Lee, J., Lee, K.-E., Wen, L., Kim, T., Park, Y.-W., & Lee, S. (2015) · Chonnam Medical Journal · doi:10.4068/cmj.2015.51.2.58 · Cited by 28
Tobacco Use in Fibromyalgia Is Associated With Cognitive Dysfunction
Ge, L., D'Souza, R. S., Oh, T. H., Vincent, A., Mohabbat, A. B., Eldrige, J. S., Jiang, L., Whipple, M. O., McAllister, S. J., Wang, Z., et al. (2019) · Mayo Clinic Proceedings Innovations Quality & Outcomes · doi:10.1016/j.mayocpiqo.2018.12.002 · Cited by 27
“Higher scores indicate more severe symptoms, with scores of 0 to <39, 39 to <59, and 59 to 100, indicating mild, moderate, and severe symptoms, respectively.(20) The 36-item Short Form Health Survey (SF-36) is a health-related quality-of-life (QOL) measure.”
BackgroundBruun, K. D., Amris, K., Vægter, H. B., Blichfeldt‐Eckhardt, M. R., Holsgaard‐Larsen, A., Christensen, R., & Toft, P. (2021) · Trials · doi:10.1186/s13063-021-05776-7 · Cited by 24
“Level of cognition: assessed by the FIQR “level of memory problems” question 11.”
MethodInfluentialDoebl, S., Hollick, R. J., Beasley, M., Choy, E., Macfarlane, G. J., & for the PACFiND Study Investigators (2021) · Arthritis Care & Research · doi:10.1002/acr.24723 · Cited by 26
“The impact of symptoms on health status was similar in both fi bromyalgia diagnosis and criteria groups (SIQR mean score 57.2 and 57.4, respectively), signi fi cantly more than in the chronic pain group (SIQR mean score 36.9, md adj versus fi bromyalgia criteria group – 20.67 [95% CI – 26.61, – 14.73]) (Table 2).”
MethodInfluentialEfficacy of acupuncture in the treatment of fibromyalgia
Berger, A. A., Liu, Y., Nguyen, J., Spraggins, R., Reed, D. S., Lee, C., Hasoon, J. J., & Kaye, A. D. (2021) · Orthopedic Reviews · doi:10.52965/001c.25085 · Cited by 63
Decreased Physical Activity Attributable to Higher Body Mass Index Influences Fibromyalgia Symptoms
Vincent, A., Clauw, D. J., Oh, T. H., Whipple, M. O., & Toussaint, L. L. (2014) · PM&R · doi:10.1016/j.pmrj.2014.02.007 · Cited by 27
Farin‐Glattacker, E., Ullrich, A., & Hauer, J. (2013) · Health and Quality of Life Outcomes · doi:10.1186/1477-7525-11-135 · Cited by 26
“(FIQ/FIQ-R [13,14]) is the only disease-specific instrument currently available (see [15]).”
BackgroundPatient-Reported Outcomes and Fibromyalgia
Williams, D. A., & Kratz, A. L. (2016) · Rheumatic Disease Clinics of North America · doi:10.1016/j.rdc.2016.01.009 · Cited by 25
“Given that pain is only 1 aspect of FM, use of the NRS as a means of monitoring the condition is likely to be insufficient.22 One instrument that has been used to monitor diverse FM symptomatology and impact overtime has been the Fibromyalgia Impact Questionnaire-Revised.23 The Fibromyalgia Impact Questionnaire-Revise…”
MethodGavilán‐Carrera, B., Segura‐Jiménez, V., Mekary, R. A., Borges‐Cosic, M., Acosta‐Manzano, P., Estévez‐López, F., Álvarez‐Gallardo, I. C., Geenen, R., & Delgado‐Fernández, M. (2018) · Arthritis Care & Research · doi:10.1002/acr.23717 · Cited by 28
Traumatic experiences and somatoform dissociation in women with fibromyalgia.
Romeo, A., Tesio, V., Ghiggia, A., Tella, M. D., Geminiani, G. C., Farina, B., & Castelli, L. (2021) · Psychological Trauma Theory Research Practice and Policy · doi:10.1037/tra0000907 · Cited by 28
“The FIQ-R has demonstrated good concurrent validity, test-retest reliability, and internal consistency with Cronbach’s α = 0.94–0.95 (Bennett et al., 2009; Salaffi et al., 2013).”
InfluentialEastwood, F., & Godfrey, E. (2024) · British Journal of Pain · doi:10.1177/20494637231221451 · Cited by 22
Correlation of hematological indices and ratios derived from them with FIQR scores in fibromyalgia
Al-Nimer, M. S. M., & Mohammad, T. A. M. (2018) · Pakistan Journal of Medical Sciences · doi:10.12669/pjms.345.15169 · Cited by 22
Effect of COVID-19 Pandemic Lockdown on Fibromyalgia Symptoms
Batres-Marroquín, A. B., Medina-García, A. C., Guerrero, A. V., Barrera-Villalpando, M.-I., Martínez‐Lavín, M., & Martínez-Martínez, L.-A. (2020) · JCR Journal of Clinical Rheumatology · doi:10.1097/rhu.0000000000001685 · Cited by 25
“Each question has a 0- to 10-point severity score.(4) Widespread Pain Index, Symptom Severity Scale, and Polysymptomatic Distress Scale were contained in Wolfe and colleagues’ fibromyalgia diagnostic criteria.”
MethodIannuccelli, C., Lucchino, B., Gioia, C., Dolcini, G., Rabasco, J., Venditto, T., Ioppolo, F., Santilli, V., Conti, F., & Franco, M. D. (2022) · Clinical Rheumatology · doi:10.1007/s10067-022-06133-y · Cited by 29
Intra- and Inter-Patient Symptom Variability in Fibromyalgia: Results of a 90-Day Assessment
Toussaint, L. L., Vincent, A., McAllister, S. J., & Whipple, M. O. (2014) · Musculoskeletal Care · doi:10.1002/msc.1090 · Cited by 21
“Care 13 (2015) 93–100 © 2014 John Wiley & Sons, Ltd. the course of the study.”
BackgroundInfluentialFibromyalgia Impact and Mindfulness Characteristics in 4986 People with Fibromyalgia
Jones, K. D., Mist, S. D., Casselberry, M. A., Ali, A., & Christopher, M. S. (2015) · EXPLORE · doi:10.1016/j.explore.2015.04.006 · Cited by 22
Self-citationA pilot study of myofascial release therapy compared to Swedish massage in Fibromyalgia
Liptan, G. L., Mist, S. D., Wright, C. L., Arzt, A. C., & Jones, K. D. (2013) · Journal of Bodywork and Movement Therapies · doi:10.1016/j.jbmt.2012.11.010 · Cited by 26
“A 14% change in the FIQ-R is considered clinically significant (Bennett et al., 2009b).”
BackgroundSelf-citationNes, L. S., Ehlers, S. L., Whipple, M. O., & Vincent, A. (2017) · Pain Practice · doi:10.1111/papr.12480 · Cited by 21
“The FIQ-R has acceptable reliability and validity.(22)”
Droppert, K., & Knowles, S. R. (2022) · Journal of Clinical Psychology in Medical Settings · doi:10.1007/s10880-022-09873-w · Cited by 26
“Due to the administrative error relating to the naming of the anchor points for the FIQ-R, the validity of the scale may have been compromised.”
InfluentialRamírez, M., Guerra-Juárez, A., Miyake, D.-Y., Sebastián-Arellano, C., Estrada-Mata, A. G., González-Moyotl, N.-J., Rodríguez-Aguayo, A.-M., Martínez‐Lavín, M., & Martínez-Martínez, L.-A. (2020) · JCR Journal of Clinical Rheumatology · doi:10.1097/rhu.0000000000001592 · Cited by 24
Salaffi, F., Farah, S., Mariani, C., Sarzi‐Puttini, P., & Carlo, M. D. (2022) · Pain Practice · doi:10.1111/papr.13162 · Cited by 23
“The FIQR is a more recent variant of the FIQ.18 It is made up of 21 items with 11- point numerical rating scales (NRS) that look at three major health domains (function, overall health status, symptoms) in relation to the previous week.”
MethodYao, S., Bao, H., Nuguri, S. M., Yu, L., Mikulik, Z., Osuna-Diaz, M. M., Sebastian, K., Hackshaw, K. V., & RODRIGUEZ‐SAONA, L. E. (2023) · Biomedicines · doi:10.3390/biomedicines11030712 · Cited by 26
“Self-reported symptoms were obtained from all subjects using the Revised Fibromyalgia Impact Questionnaire (FIQR), a 10-item self-rating instrument that measures physical functioning, work status, depression, anxiety, sleep, pain, stiffness, fatigue, and wellbeing [31].”
MethodImpact of fibromyalgia severity on patients mood, sleep quality, and quality of life
Singh, R., Rai, N. K., Pathak, A., Rai, J., Pakhare, A. P., Kashyap, P. V., Rozatkar, A. R., Mishra, S., & Mudda, S. (2024) · Journal of Neurosciences in Rural Practice · doi:10.25259/jnrp_14_2024 · Cited by 25
“[20] Higher scores indicate worse symptoms.”
Nasser, K. M., Kivitz, A., Maricic, M. J., Silver, D., & Silverman, S. L. (2013) · Arthritis Care & Research · doi:10.1002/acr.22111 · Cited by 23
“A responder analysis for the FIQR was also completed.”
MethodInfluentialSegura‐Jiménez, V., Castro‐Piñero, J., Soriano‐Maldonado, A., Álvarez‐Gallardo, I. C., Estévez‐López, F., Delgado‐Fernández, M., Carbonell‐Baeza, A., & the al‐Ándalus project. (2015) · European Journal of Pain · doi:10.1002/ejp.807 · Cited by 25
“The Revised Fibromyalgia Impact Questionnaire (FIQR) is a self-administered questionnaire, comprising 21 individual questions with a rating scale of 0–10 (Bennett et al., 2009).”
MethodA Report of the Autonomic Symptom Profile in Patients With Fibromyalgia
Vincent, A., McAllister, S. J., Singer, W., Toussaint, L. L., Sletten, D. M., Whipple, M. O., & Low, P. A. (2014) · JCR Journal of Clinical Rheumatology · doi:10.1097/rhu.0b013e3182a225dd · Cited by 21
“Total scores range from 0 to 100, with higher scores indicating more severe symptoms.(13)”
BackgroundD'Souza, R. S., Lin, G., Oh, T. H., Vincent, A., Orhurhu, V., Jiang, L., Mauck, W. D., & Qu, W. (2019) · Pain Medicine · doi:10.1093/pm/pnz377 · Cited by 22
Bennett, R. M., Russell, I. J., Choy, E., Spaeth, M., Mease, P. J., Kajdasz, D. K., Walker, D. J., Wang, F., & Chappell, A. S. (2012) · Clinical Therapeutics · doi:10.1016/j.clinthera.2012.02.013 · Cited by 22
Self-citationAbu-Dahab, S., Aburuz, S., Mustafa, K. N., & Sarhan, Y. (2013) · Clinical Rheumatology · doi:10.1007/s10067-013-2347-7 · Cited by 21
Arfuch, V. M., Angelats, R. C., Martín, C. A., Gonçalves, A. Q., Carrasco-Querol, N., Serra, G. G., Sol, M. C. S., Anguera, I. F., Friberg, E., & Berenguera, A. (2022) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph192013322 · Cited by 29
“Public Health 2022, 19, x FOR PEER REVIEW6 of 21 P3 phone 3 59 divorced working primary IVb 2 12 92% 88.67 8 P4 face-to-face 1 51 married unemployed primary IVb 13 12 75% 78.17 8 P5 phone 1 54 divorced disabled secondary IVa 11 6 83% 96.33 8 P6 phone 2 45 married une - ployed secondary II 2 5 75% 42.17 7 P7 phone 1 71…”
BackgroundInfluentialBested, K., Jensen, L. M., Andresen, T., Tarp, G., Skovbjerg, L., Johansen, T. S. D., Schmedes, A., Storgaard, I. K., Madsen, J. S., Werner, M. U., et al. (2023) · PAIN Reports · doi:10.1097/pr9.0000000000001080 · Cited by 30
Cao, H., Liu, J., Hu, H., & Wang, N. S. (2014) · Trials · doi:10.1186/1745-6215-15-280 · Cited by 20
“Revised Fibromyalgia Impact Questionnaire (FIQR, Chinese translation) for pain intensity [30]: The FIQR will be implemented three times, at weeks 0, 5, and 17 (Table 1).”
MethodPharmacotherapy for Fibromyalgia
Smith, H. S., Bracken, D., & Smith, J. M. (2011) · Frontiers in Pharmacology · doi:10.3389/fphar.2011.00017 · Cited by 23
“There was good correlation between the FIQR and comparable domains in the Medical Outcomes Study Short Form 36 (SF-36), with a multiple regression analysis showing that the three FIQR domain scores predicted the eight SF-36 subscale scores (Bennett et al., 2009b).”
BackgroundMethodInfluentialTreat‐to‐Target Strategy for Fibromyalgia: Opening the Dialogue
Häuser, W., Clauw, D. J., & Fitzcharles, M. (2016) · Arthritis Care & Research · doi:10.1002/acr.22970 · Cited by 20
Collado‐Mateo, D., Chen, G., García-Gordillo, M. Á., Iezzi, A., Adsuar, J. C., Olivares, P. R., & Gusi, N. (2017) · Health and Quality of Life Outcomes · doi:10.1186/s12955-017-0690-0 · Cited by 22
“It evaluates the impact of FM addressing the limitations encountered in the FIQ while retaining the essential properties of the original instrument [5].”
BackgroundMethodResultInfluentialMindfulness is associated with sleep quality among patients with fibromyalgia
Park, M., Zhang, Y., Price, L. L., Bannuru, R. R., & Wang, C. (2019) · International Journal of Rheumatic Diseases · doi:10.1111/1756-185x.13756 · Cited by 26
Fibromyalgia Syndrome: A Discussion of the Syndrome and Pharmacotherapy
Smith, H. S., & Barkin, R. L. (2011) · Disease-a-Month · doi:10.1016/j.disamonth.2011.02.001 · Cited by 24
Akdogan, S., Ayhan, F. F., Yıldırım, Ş., & Borman, P. (2013) · Journal of Musculoskeletal Pain · doi:10.3109/10582452.2013.806977 · Cited by 20
Antunes, M. D., Loures, F. C. N. D. R., de Souza, I. M. B., Cruz, A. T., Januário, P. D. O., Pinheiro, M. M. L. S., Schmitt, A. C. B., Frutos‐Bernal, E., Nogueras, A. M. M., & Marques, A. P. (2023) · Trials · doi:10.1186/s13063-023-07588-3 · Cited by 23
“Quality of life The Fibromyalgia Impact Questionnaire (FIQ) was first developed by Burckardt, Clark, and Ben-nett [46], and translated and adapted to the Brazilian population by Marques et al. [47], reviewed by Bennett et al. [48] and validated for Brazil by Paiva et al. [49] will be used.”
MethodPsychometric Properties of the Fibromyalgia Survey Questionnaire in Chilean Women With Fibromyalgia
Cárdenas, C. A., Oñederra, M. C., Benavente, C. E., Durán, J., Tugas, M. G., & Gómez‐Pérez, L. (2020) · JCR Journal of Clinical Rheumatology · doi:10.1097/rhu.0000000000001547 · Cited by 19
Interactions between affect, cognition, and information behavior in the context of fibromyalgia
Chen, A. (2021) · Journal of the Association for Information Science and Technology · doi:10.1002/asi.24538 · Cited by 24
“Last, participants were asked to complete the Fibromyalgia Impact Questionnaire—Revised version (FIQR) (Bennett et al., 2009), a general assessment of the impact of fibromyalgia.”
BackgroundMethodInfluentialGhavidel‐Parsa, B., Bidari, A., Atrkarroushan, Z., & Khosousi, M. (2021) · ACR Open Rheumatology · doi:10.1002/acr2.11390 · Cited by 26
“The total FIQR score was the sum of the three modified domain scores (24).”
BackgroundAssociation of physical fitness and fatness with cognitive function in women with fibromyalgia
Soriano‐Maldonado, A., Artero, E. G., Segura‐Jiménez, V., Aparicio, V. A., Estévez‐López, F., Álvarez‐Gallardo, I. C., Munguía‐Izquierdo, D., Casimiro-Andújar, A. J., Delgado‐Fernández, M., & Ortega, F. B. (2016) · Journal of Sports Sciences · doi:10.1080/02640414.2015.1136069 · Cited by 24
“Model 2: model 1 + depression (Beck Depression Inventory total score), pain (visual analogue scale and pain subscale from the Revised Fibromyalgia Impact Questionnaire) and stimulants’ consumption.”
MethodInfluentialBowers, H. M., Wroe, A. L., & Pincus, T. (2017) · Clinical Rheumatology · doi:10.1007/s10067-017-3590-0 · Cited by 25
“There is evidence of excellent internal consistency of the FIQr (Cronbach’s alpha = 0.95), and correlations with the original FIQ were good (r = .65 for overall scores) as were correlations of all domains with the subscales of the Short Form (36) Health Survey [30].”
MethodInfluentialMolinari, G., Miragall, M., Enrique, Á., Botella, C., Baños, R., & García‐Palacios, A. (2019) · European Journal of Pain · doi:10.1002/ejp.1481 · Cited by 21
“R; Bennett et al., 2009).”
BackgroundAngelats, R. C., Gonçalves, A. Q., Martín, C. A., Sol, M. C. S., Serra, G. G., Casajuana‐Closas, M., Carrasco-Querol, N., Fernández‐Sáez, J., Llorca, M. R. D., Abellana, R. M., et al. (2019) · Medicine · doi:10.1097/md.0000000000017289 · Cited by 22
“license number QM048943), Revised Fibromyalgia Impact Questionnaire (FIQR),([43,44]) Visual Analog Scale (VAS),([45,46]) tender points([47]) and Hospital Anxiety and Depression Scale (HADS)([48,49])) and will take part in the activities planned for each group (see below).”
BackgroundOpioid Use in Fibromyalgia Continues Despite Guidelines That Do Not Support Its Efficacy or Risk
Bruce, B. K., Allman, M. E., Rivera, F. A., Abril, A., Gehin, J. M., Oliphant, L. M., Nordan, L. M., White, L. J., Martinez, D., & Niazi, S. K. (2020) · JCR Journal of Clinical Rheumatology · doi:10.1097/rhu.0000000000001273 · Cited by 22
Assessing our approach to diagnosing Fibromyalgia
Hackshaw, K. V. (2020) · Expert Review of Molecular Diagnostics · doi:10.1080/14737159.2020.1858054 · Cited by 23
The validity and reliability of the Persian version of the Revised Fibromyalgia Impact Questionnaire
Ghavidel‐Parsa, B., Maafi, A. A., Haghdoost, A., Arabi, Y. M., Khojamli, M., Chatrnour, G., & Bidari, A. (2013) · Rheumatology International · doi:10.1007/s00296-013-2929-3 · Cited by 19
“have updated this instrument as the Revised Fibromyalgia Impact Questionnaire (FIQR) to modify problems while retaining the essential properties of the previous version [5, 6].”
BackgroundMethodResultInfluentialAmidei, J., Nieto, R., Kaltenbrunner, A., Sá, J. G. F. D., Serrat, M., & Albajes, K. (2025) · Journal of Medical Internet Research · doi:10.2196/65903 · Cited by 21
“The inclusion criteria for these participants were (1) fulfillment of the 2010/2011 American College of Rheumatology Fibromyalgia diagnostic criteria [33] and (2) age of 18 years or older.”
Chang, E. C., Lucas, A. G., Chang, O. D., Angoff, H. D., Li, M., Duong, A. H., Huang, J., Perera, M. J., Sirois, F. M., & Hirsch, J. K. (2019) · Social Work · doi:10.1093/sw/swz013 · Cited by 24
Performance of 2016 revised fibromyalgia diagnostic criteria in patients with rheumatoid arthritis
Shresher, N. M., Mohamed, A. E., & Elshahaly, M. H. (2019) · Rheumatology International · doi:10.1007/s00296-019-04403-8 · Cited by 21
Pérez‐Aranda, A., Feliu‐Soler, A., Mist, S. D., Jones, K. D., del Hoyo, Y. L., Oliván-Arévalo, R., Kratz, A. L., Williams, D. A., & Luciano, J. V. (2020) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph18010247 · Cited by 20
“, FIQR) [18] has been used to classify subtypes of patients in Italy [19] and Spain [11].”
MethodSelf-citationImpact of isometric and concentric resistance exercise on pain and fatigue in fibromyalgia
Berardi, G., Senefeld, J. W., Hunter, S. K., & Bement, M. H. (2021) · European Journal of Applied Physiology · doi:10.1007/s00421-021-04600-z · Cited by 23
Temporal Summation in Fibromyalgia Patients: Comparing Phasic and Tonic Paradigms
Castelo-Branco, L., Cardenas‐Rojas, A., Rebello‐Sanchez, I., Pacheco‐Barrios, K., de Melo, P. S., Gonzalez‐Mego, P., Marduy, A., Vásquez-Ávila, K., Cortez, P. C., Parente, J., et al. (2022) · Frontiers in Pain Research · doi:10.3389/fpain.2022.881543 · Cited by 19
Pelvic Floor and Urinary Distress in Women with Fibromyalgia
Jones, K. D., Maxwell, C., Mist, S. D., King, V. G., Denman, M. A., & Gregory, W. T. (2015) · Pain Management Nursing · doi:10.1016/j.pmn.2015.06.001 · Cited by 21
“Higher scores on the FIQR total score (range 0-100) indicate greater negative impact of FM on overall functioning; an FIQR total score of 0-39 represents mild symptoms, 40-58 represents moderate symptoms, and 59-100 represents severe impact on overall functioning (Bennett et al., 2009).”
BackgroundSelf-citationSegura‐Jiménez, V., Soriano‐Maldonado, A., Estévez‐López, F., Álvarez‐Gallardo, I. C., Delgado‐Fernández, M., Ruiz, J. R., & Aparicio, V. A. (2016) · Journal of Sports Sciences · doi:10.1080/02640414.2016.1225971 · Cited by 21
“The Revised Fibromyalgia Impact Questionnaire (FIQR) is a selfadministered questionnaire, comprising 21 individual questions with a rating scale of 0–10 (Bennett et al., 2009).”
MethodFibromyalgia Outcomes Over Time: Results from a Prospective Observational Study in the United States
Schaefer, C. P., Adams, E. H., Udall, M., Masters, E. T., Mann, R., Daniel, S. R., McElroy, H. J., Cappelleri, J. C., Clair, A. G., Hopps, M., et al. (2016) · The Open Rheumatology Journal · doi:10.2174/1874312901610010109 · Cited by 25
“* Note that the FIQ-R was administered to patients who were re-diagnosed with fibromyalgia by the physician at Follow-up.”
MethodInfluentialTrainor, H., Baranoff, J., Henke, M., & Winefield, H. (2019) · Australian Psychologist · doi:10.1111/ap.12363 · Cited by 18
“…good construct validity by showing high correlations with relevant domains of the Medical Outcome Study Short Form (SF-36), and has shown good ability to discriminate between a fibromyalgia group and those with rheumatoid arthritis, depression, and healthy controls (Bennett et al., 2009).”
BackgroundMethodInfluentialClinical association of vitamin D and serotonin levels among patients with fibromyalgia syndrome
Amin, O. A., Abouzeid, S. M., Ali, S. A., Amin, B. A., & Alswat, K. A. (2019) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s198434 · Cited by 19
“The questionnaire consisted of two parts: a demographic questionnaire and the revised Fibromyalgia Impact Questionnaire (FIQR).(19) The demographic questionnaire included the age, sex, educational status, income level, body mass index (BMI), daily caffeinated beverage consumption, smoking status, and medication usage.”
BackgroundMethodInfluentialContinuing efficacy of milnacipran following long-term treatment in fibromyalgia: a randomized trial
Clauw, D. J., Mease, P. J., Palmer, R. H., Trugman, J. M., & Wang, Y. (2013) · Arthritis Research & Therapy · doi:10.1186/ar4268 · Cited by 18
“This study also demonstrated that improvements in global status (PGIC), fibromyalgia severity (FIQR) and physical functioning (SF-36 PCS) occurred in patients receiving long-term milnacipran treatment.”
InfluentialJiang, L., D'Souza, R. S., Oh, T. H., Vincent, A., Mohabbat, A. B., Ashmore, Z. M., Mauck, W. D., Lin, G., Whipple, M. O., McAllister, S. J., et al. (2020) · Mayo Clinic Proceedings Innovations Quality & Outcomes · doi:10.1016/j.mayocpiqo.2020.06.009 · Cited by 19
Calandre, E. P., Hidalgo‐Tallon, J., Molina-Barea, R., Rico‐Villademoros, F., Molina‐Hidalgo, C., Garcia‐Leiva, J. M., Carrillo‐Izquierdo, M. D., & Slim, M. (2021) · Pharmaceuticals · doi:10.3390/ph14101063 · Cited by 19
“The total score of the FIQR ranges from 0 to 100, and the higher the score, the greater the severity of fibromyalgia.”
MethodInfluentialDorris, E., Maccarthy, J., Simpson, K., & McCarthy, G. (2022) · Frontiers in Pain Research · doi:10.3389/fpain.2022.926331 · Cited by 19
Depression: A Modifiable Risk Factor for Poor Outcomes in Fibromyalgia
Munipalli, B., Allman, M. E., Chauhan, M., Niazi, S. K., Rivera, F., Abril, A., Wang, B., Wieczorek, M. A., Hodge, D. O., Knight, D. R. T., et al. (2022) · Journal of Primary Care & Community Health · doi:10.1177/21501319221120738 · Cited by 25
Burgess, H. J., Bahl, S., Wilensky, K., Spence, E., Jouppi, R. J., Rizvydeen, M., Goldstein, C. A., Kim, H. M., Williams, D. A., & Burns, J. W. (2023) · Pain Medicine · doi:10.1093/pm/pnad007 · Cited by 21
de Sousa, A. P., Almeida, L. A., Lourenço, B. P., Alvares, L. D., & Ávila, M. A. (2023) · Disability and Rehabilitation · doi:10.1080/09638288.2023.2201510 · Cited by 23
Mast Cell Stabilizer (Ketotifen) in Fibromyalgia: Phase 1 Randomized Controlled Clinical Trial
Ang, D. C., Hilligoss, J., & Stump, T. E. (2014) · Clinical Journal of Pain · doi:10.1097/ajp.0000000000000169 · Cited by 20
Reneau, M. G. (2020) · The Journal of Alternative and Complementary Medicine · doi:10.1089/acm.2020.0071 · Cited by 17
Diagnostic and therapeutic care pathway for fibromyalgia
Sarzi‐Puttini, P., Giorgi, V., Atzeni, F., Gorla, R., Kosek, E., Choy, E., Bazzichi, L. M., Häuser, W., Ablin, J. N., Aloush, V., et al. (2021) · Clinical and Experimental Rheumatology · doi:10.55563/clinexprheumatol/zcp5hz · Cited by 26
“This assessment can be carried out using disease-specific clinimetric tests and scales (50), such as the FM Impact Questionnaire (51) and its revised version (52, 53) and the FM Assessment Status (54, 55), with its modified form (56).”
MethodFibromyalgia in primary antiphospholipid (Hughes) syndrome
Costa, S., Lage, L., Mota, L., & de Carvalho, J. F. (2011) · Lupus · doi:10.1177/0961203311411962 · Cited by 17
Lederman, S. M., Arnold, L. M., Vaughn, B. J., Engels, J., Kelley, M. A., & Sullivan, G. M. (2025) · Pain Medicine · doi:10.1093/pm/pnaf089 · Cited by 23
“In clinic, patients completed the Patient Global Impression of Change (PGIC) scale, 31 the Fibromyalgia Impact Questionnaire (Revised; FIQR), 32 and the Patient-Reported Outcomes Measurement Information System (PROMIS) questionnaires 33 for Sleep Disturbance and Fatigue at weeks 2, 6, 10, and 14.”
Singh, R., Rai, N. K., Rastogi, A., Endukuru, C. K., Joshi, A., & Mishra, S. S. (2021) · Journal of Basic and Clinical Physiology and Pharmacology · doi:10.1515/jbcpp-2020-0007 · Cited by 16
The “self” in pain: high levels of schema-enmeshment worsen fibromyalgia impact
Paschali, M., Lazaridou, A., Vilsmark, E. S., Lee, J., Berry, M., Grahl, A., Anzolin, A., Loggia, M. L., Napadow, V., & Edwards, R. R. (2021) · BMC Musculoskeletal Disorders · doi:10.1186/s12891-021-04740-5 · Cited by 19
Donisi, V., Lucia, A. D., Pasini, I., Gandolfi, M., Schweiger, V., Piccolo, L. D., & Perlini, C. (2023) · Healthcare · doi:10.3390/healthcare11131845 · Cited by 26
“AAQ-II, acceptance and action questionnaire II [75]; ACT, acceptance and commitment therapy; ALS, activities limitation scale [76]; ASES, arthritis self-efficacy scale [77]; ASI-3, anxiety sensitivity index 3 [78]; BBQ, Brunnsviken brief quality of life scale [79]; BDI-II, Beck depression inventory [80]; BPI-SF, brief…”
Hackshaw, K. V., Yao, S., Bao, H., Castellví, S. D. L., Aziz, R., Nuguri, S. M., Yu, L., Osuna-Diaz, M. M., Brode, W. M., Sebastian, K., et al. (2023) · Biomedicines · doi:10.3390/biomedicines11102704 · Cited by 17
“Questionnaires: All subjects with FM provided a self-report of symptoms through the use of the Revised Fibromyalgia Impact Questionnaire (FIQR), a 10-item self-rating instrument that measures physical functioning, work status, depression, anxiety, sleep, pain, stiffness, fatigue, and wellbeing [49].”
MethodEarly Diagnosis of Fibromyalgia Using Surface-Enhanced Raman Spectroscopy Combined with Chemometrics
Bao, H., Hackshaw, K. V., Castellví, S. D. L., Wu, Y., Gonzalez, C. M., Nuguri, S. M., Yao, S., Goetzman, C. M., Schultz, Z. D., Yu, L., et al. (2024) · Biomedicines · doi:10.3390/biomedicines12010133 · Cited by 17
“The Beck Depression Inventory (BDI) is a 21-item, self-report rating inventory that measures characteristic attitudes and symptoms of depression [26].”
Suicidality in Fibromyalgia: A Systematic Review of the Literature
Levine, D. S., & Horesh, D. (2020) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2020.535368 · Cited by 25
“nnaire – Revised (43); BDI, Beck Depression Inventory (44); ICD-9, International”
BackgroundDyadic and Solitary Sexual Desire in Patients With Fibromyalgia: A Controlled Study
López‐Rodriguez, M. M., Pérez‐Fernández, A., Hernández‐Padilla, J. M., Fernández‐Sola, C., Fernández‐Medina, I. M., & Granero‐Molina, J. (2019) · The Journal of Sexual Medicine · doi:10.1016/j.jsxm.2019.07.026 · Cited by 17
Yang, Y., Li, Y., Sun, Y.-R., Wang, J., Li, Y., Zhang, J., Jiao, J., & Jiang, Q. (2021) · Rheumatology and Therapy · doi:10.1007/s40744-021-00341-9 · Cited by 15
Gharibpoor, F., Ghavidel‐Parsa, B., Sattari, N., Bidari, A., Nejatifar, F., & Montazeri, A. (2022) · BMC Rheumatology · doi:10.1186/s41927-022-00282-y · Cited by 21
“Outcome measures The FIQR is a 21-items questionnaire with an 11-point numeric rating scale for each question which assesses clinical symptom severity and disease impact in patients with FM [22].”
MethodDöhmen, A., Kock, M., Fischer, F. H., Rose, M., Obbarius, A., & Klapproth, C. P. (2022) · Quality of Life Research · doi:10.1007/s11136-022-03261-5 · Cited by 17
“The revised FIQ (FIQ-R), published in 2009, additionally covers the domains memory, tenderness, balance, and environmental sensitivity [9].”
MethodRivera, F. A., Munipalli, B., Allman, M. E., Hodge, D. O., Wieczorek, M. A., Wang, B. X., Abril, A., Perlman, A. I., Knight, D. R. T., & Bruce, B. K. (2024) · Frontiers in Medicine · doi:10.3389/fmed.2023.1301944 · Cited by 17
“According to this criteria, widespread pain, tender trigger points, and the updated comprehensive evaluation symptoms and their impact on a person quality of life are the main elements to make a FM diagnosis currently (3, 5, 6, 12).”
BackgroundCircadian Rhythm of Serum Cortisol in Female Patients with Fibromyalgia Syndrome
Fatima, G., Das, S. K., Mahdi, A. A., Verma, N. S., Khan, F. H., Tiwari, A. M. K., Jafer, T., & Anjum, B. (2012) · Indian Journal of Clinical Biochemistry · doi:10.1007/s12291-012-0258-z · Cited by 21
“indicating very severe) [13].”
Srifi, N., Bahiri, R., Rostom, S., Bendeddouche, I., Lazrek, N., & Hajjaj-Hassouni, N. (2012) · Rheumatology International · doi:10.1007/s00296-011-2331-y · Cited by 15
“The Revised Fibromyalgia Impact Questionnaire (FIQ-R) is an updated version of the FIQ [7], developed by Bennett et al.”
MethodColomer‐Carbonell, A., Sanabria‐Mazo, J. P., Hernández-Negrín, H., Borràs, X., Suso‐Ribera, C., García‐Palacios, A., Muchart, J., Munuera, J., D’Amico, F., Maes, M. H. J., et al. (2022) · BMJ Open · doi:10.1136/bmjopen-2021-055351 · Cited by 20
Ledesma, S. N., González-Muñoz, A., Carroll, J. D., & Burton, P. (2022) · Therapeutic Advances in Chronic Disease · doi:10.1177/20406223221078095 · Cited by 18
Brown, T. J., Hammond, A., Ching, A., & Parker, J. L. (2023) · Musculoskeletal Care · doi:10.1002/msc.1760 · Cited by 15
Post-traumatic stress disorder symptoms may explain poor mental health in patients with fibromyalgia
Toussaint, L. L., Whipple, M. O., & Vincent, A. (2015) · Journal of Health Psychology · doi:10.1177/1359105315611957 · Cited by 15
“The Fibromyalgia Impact Questionnaire—Revised (FIQ-R) is a validated, 21-item self-report questionnaire used to characterize the severity and impact of fibromyalgia symptoms (Bennett et al., 2009b).”
BackgroundMethodInfluentialZhang, Y., Liang, D., Jiang, R., Ji, X., Wang, Y., Zhu, J., Zhang, J., & Huang, F. (2017) · Clinical Rheumatology · doi:10.1007/s10067-017-3872-6 · Cited by 16
Association Between Sexual Dysfunction, Sleep Impairment and Depression in Women with Fibromyalgia
Dursun, M., Beşiroğlu, H., Tellioğlu, E., Sağlam, Y., & Ortaç, M. (2019) · Sexuality and Disability · doi:10.1007/s11195-019-09592-5 · Cited by 15
Villafaina, S., Gusi, N., Rodriguez-Generelo, S., Martin-Gallego, J. D. D., García, J. P. F., & Collado‐Mateo, D. (2019) · BioMed Research International · doi:10.1155/2019/5132802 · Cited by 18
Serrat, M., Ferrés, S., Auer, W., Almirall, M., Lluch, E., D’Amico, F., Maes, M. H. J., Lorente, S., Navarrete, J., Montero‐Marín, J., et al. (2022) · Frontiers in Physiology · doi:10.3389/fphys.2022.1046613 · Cited by 18
“In addition, to assess clinical significance of the improvement on the primary outcome (FIQR), all the participants will be allocated into the categories of “responder” and “non-responder” by using the criteria of presenting at least a 20% reduction in the pre–post FIQR total score or not, respectively (Bennett et al.…”
MethodRational treatment of fibromyalgia for a solo practitioner
Paiva, E. S., & Jones, K. D. (2010) · Best Practice & Research Clinical Rheumatology · doi:10.1016/j.berh.2009.12.010 · Cited by 17
Self-citationAmirova, A., Cropley, M., & Theadom, A. (2016) · International Journal of Stress Management · doi:10.1037/str0000017 · Cited by 15
Metadata
- Authors
- Bennett, R. M., Friend, R., Jones, K. D., Ward, R., Han, B. K., & Ross, R. L.
- Affiliations
- Oregon Health & Science University (US)
- Corresponding author
- Bennett, Robert M
- Venue
- Arthritis Research & Therapy
- Published
- 2009-08-10
- Volume
- 11
- Issue
- 4
- Pages
- R120-R120
- ISSN
- 1478-6354 (ISSN-L)
- PMC
- PMC2745803
- OpenAlex
- W2042116454
- Cited by
- 814
- References
- 28
- Citations by year
- 2026: 78 · 2025: 70 · 2024: 65 · 2023: 82 · 2022: 76 · 2021: 70 · 2020: 59 · 2019: 46 · 2018: 33 · 2017: 37 · 2016: 40 · 2015: 37 · 2014: 30 · 2013: 25 · 2012: 25
- FWCI
- 13.16
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/2.0/ (tdm)
- creativecommons.org/licenses/by/2.0/ (vor)
- Locations
- Arthritis Research & Therapy (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Fibromyalgia and Chronic Fatigue Syndrome Research
- Health Sciences › Health Professions › Physical Therapy, Sports Therapy and Rehabilitation › Musculoskeletal pain and rehabilitation
- Health Sciences › Medicine › Psychiatry and Mental health › Psychosomatic Disorders and Their Treatments
- Keywords
- fibromyalgia, Fibromyalgia Impact Questionnaire, patient-reported outcome measures, questionnaire validation, psychometric properties, SF-36, environmental sensitivity, tenderness, memory, balance, rheumatoid arthritis, systemic lupus erythematosus, major depressive disorder, scoring algorithm, discriminant validity
- MeSH terms
- Algorithms, Female, Fibromyalgia, Humans, Middle Aged, Psychometrics, Surveys and Questionnaires, Severity of Illness Index, Reproducibility of Results, Focus Groups
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.